ObjectiveTo explore the effect of recombinant human growth hormone (rhGH) on the lipid metabolism of fatty liver cell model induced in vitro, and to provide theoretical support for further expanding the application of rhGH in clinical practice.MethodsPalmitic acid (PA) was combined to induce lipid accumulation in HepG2 cells, and a fatty liver cell model was constructed. The cell model was treated with different concentrations of rhGH, and CCK8 assay was used to detect the effects of different concentrations of PA and rhGH on the survival of HepG2 cells. The lipid accumulation level in HepG2 cells was evaluated by oil red O staining, the expression levels of genes and proteins related to lipid metabolism in HepG2 cell lines were evaluated by RT-qPCR and Western blot, and the mechanism of action of rhGH was preliminarily explored.ResultsIn this study, 0.2 mmol/L PA successfully induced a fatty liver cell model, which showed significant accumulation of lipid droplets in the cytoplasm. After being stimulated by rhGH, the accumulation of intracellular lipid droplets decreased with the increase of rhGH concentration, and the rhGH concentration of 40 ng/mL achieved a significant lipid-lowering effect. The results of RT-qPCR and Western blot showed that the expression of genes and proteins related to lipid synthesis in cells were significantly down-regulated after rhGH treatment, while the expressions of genes and proteins related to lipolysis had no significant changes.ConclusionrhGH can alleviate the lipid deposition in HepG2 cells induced by PA by inhibiting the de novo fatty acid synthesis pathway.